Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 JUN 15 ... with 9% chocolatized sheep blood, containing polymyxin B, amphotericin B, cyclohexamide, cefepime and vancomycin (CHAB-PACCV) was developed and evaluated for growth of Francisella ...
2009 JUL 20 ... we evaluated the in vitro activity of ceftaroline combined with meropenem, aztreonam, cefepime, tazobactam, amikacin, levofloxacin, and tigecycline. Susceptibility testing was ...
2009 JUN 29 ... 10 AmpC beta-lactamase variants. Reduced susceptibility to imipenem, ceftazidime, and cefepime was observed only with recombinant P. aeruginosa strains expressing an AmpC ...
2009 SEP 14 ... total of 264 isolates were subjected to cefazolin, ceftriaxone, cefotaxime, ceftazidime, cefepime, and aztreonam agar dilution MIC determination; ESBL screening and confirmatory testing ...
2009 JUL 13 ... to piperacillin (PIP), PIP-tazobactam (TZP), ceftazidime (CAZ), aztreonam (ATM) cefepime (FEP) and imipenem (IMP). The results obtained by the RM were compared with those ...
2009 JUL 27 ... Minimum inhibitory concentrations were determined for imipenem, cephalosporins (cefepime and cefpirome), ciprofloxacin, and piperacillin-tazobactam, and drug resistance rates ...
2009 SEP 14 ... beta-lactam antimicrobials that have been studied for continuous infusion, such as cefepime, ceftazidime, piperacillin, ticarcillin, clavulanic acid, and tazobactam, are ...
2009 JUL 20 ... ponA mutant and triple mutants to extended spectrum cephalosporins (ceftriaxone and cefepime) identified either PbpF or PonA as essential partners of Pbp5 for peptidoglycan ...
2009 NOV 16 ... rates than IND-5 and higher activities than IND-2 and IND-5 against ceftazidime and cefepime." Zeba and colleagues published their study in Antimicrobial Agents and ...
2009 AUG 31 ... cultures were monitored for 60 min. The peptide was synergistic with beta-lactam cefepime in most of the clinical MDR isolates tested (7/8). An average value of FIC was 0.3708. ...
2009 NOV 9 ... parapsilosis. Seven of 10 patients were treated with a combination of intravenous cefepime, 4-6 g/d. plus high-dose tobramycin (HDT) for at least 6 weeks. Tobramycin, 8 mg/kg per ...
2009 AUG 24 ... strains. A common mechanism of P. aeruginosa resistance to beta-lactams, including cefepime and ceftazidime, is efflux via increased expression of Mex pumps, especially MexAB," ...
2009 SEP 14 ... or the traditional dosage of meropenem after failure of or intolerance to cefepime for treatment of febrile neutropenia. Retrospective, single-center cohort study." ...
2009 AUG 24 ... France, "Acinetobacter baumannii isolate KAR was uncommonly more resistant to cefepime and cefpirome than to ceftazidime and cefotaxime. Cloning and expression of the ...
2009 JUN 29 ... (RND) transporter MexY was able to increase pump-promoted resistance to aminoglycosides, cefepime, and fluoroquinolones twofold. The inactivation of the mexB gene (which codes for the ...
2009 AUG 24 ... of S. pneumoniae to penicillin (85% resistance), ceftriaxone (46%/20%), and cefepime (43%/15%) by meningitis criteria, and in contrast, non-susceptibilities ...
